A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases

CR Isasi, RM Moadel, MD Blaufox - Breast cancer research and treatment, 2005 - Springer
Objective. To evaluate the diagnostic performance of 18 F-2-deoxy-2-fluoro-d-glucose-
positron emission tomography (FDG-PET) in the evaluation of breast cancer recurrence and …

[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective …

MG Hildebrandt, O Gerke, C Baun, K Falch… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To prospectively investigate the diagnostic accuracy of [18F] fluorodeoxyglucose
(FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point …

FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis

LL Pan, Y Han, XG Sun, JJ Liu, H Gang - Journal of cancer research and …, 2010 - Springer
Background and purpose Breast carcinoma is the most common cancer in female patients
with a propensity for recurrence and metastases. The accuracy of ultrasound (US) …

Role of positron emission tomography for the monitoring of response to therapy in breast cancer

O Humbert, A Cochet, B Coudert… - The …, 2015 - academic.oup.com
This review considers the potential utility of positron emission tomography (PET) tracers in
the setting of response monitoring in breast cancer, with a special emphasis on glucose …

Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management

E Piperkova, B Raphael, ME Altinyay… - Clinical nuclear …, 2007 - journals.lww.com
Purpose: To evaluate the impact of F-18 fluorodeoxyglucose (FDG) positron emission
tomography with fused computerized tomography (PET/CT) in comparison with same day …

Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma

K Manohar, BR Mittal, R Senthil… - Nuclear medicine …, 2012 - journals.lww.com
Purpose Although initial studies have shown the utility of fluorine-18 fluorodeoxyglucose (F-
18 FDG) PET in the detection and restaging of recurrent breast carcinoma, scarce literature …

Standardized uptake values from PET/MRI in metastatic breast cancer: An organ‐based comparison with PET/CT

AC Pujara, RA Raad, F Ponzo, C Wassong… - The breast …, 2016 - Wiley Online Library
Quantitative standardized uptake values (SUV s) from fluorine‐18 (18F) fluorodeoxyglucose
(FDG) positron emission tomography/computed tomography (PET/CT) are commonly used …

18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis

S Hong, J Li, S Wang - Surgical oncology, 2013 - Elsevier
BACKGROUND: We performed a meta-analysis to evaluate the value of 18FDG PET-CT for
diagnosis of distant metastases in breast cancer patients. METHODS: Studies about PET-CT …

Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer

LM Sawicki, J Grueneisen, BM Schaarschmidt… - European journal of …, 2016 - Elsevier
Objectives To compare the diagnostic performance of 18 F-fluordesoxyglucose positron
emission tomography/magnetic resonance imaging (18 F-FDG PET/MRI) with 18 F-FDG …

The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET

ME Schneider-Kolsky, S Hart, J Fox, P Midolo… - Breast Cancer …, 2010 - Springer
Introduction The aims of this study were to investigate whether drug sequence (docetaxel
followed by anthracyclines or the drugs in reverse order) affects changes in the maximal …